Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALGS
CRVO
Add up to 3 more stocks
ALGS
Aligos Therapeutics, Inc.
+0.74%
$5.44+0.04Delayed quote: Oct 6, 2026, 12:57 PM EDT
Market Cap
$33.66M
52W Range
$3.98 - $13.69
CRVO
CervoMed Inc.
-2.11%
$3.24-0.07Delayed quote: Oct 6, 2026, 1:09 PM EDT
Market Cap
$30.00M
52W Range
$2.13 - $10.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.06 | 1.31 |
| P/S Ratio | 1.07 | 93.00 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 57.5% | 0.0% |
| Operating Margin | -4024.9% | 0.0% |
| Net Margin | -241.0% | -9408.8% |
| ROE | -238.2% | -132.2% |
| ROA | -114.5% | -116.8% |
| ROIC | -208.0% | -135.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.19 | 8.57 |
| Quick Ratio | 2.19 | 8.57 |
| Debt/Equity | 0.11 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.